Literature DB >> 27770340

Increasing the Number of Examined Lymph Nodes is a Prerequisite for Improvement in the Accurate Evaluation of Overall Survival of Node-Negative Gastric Cancer Patients.

Jingyu Deng1, Hiroharu Yamashita2, Yasuyuki Seto3, Han Liang4.   

Abstract

BACKGROUND: This study aims to elucidate whether increasing the number of examined lymph nodes (NELN) is mandatory for the accurate prognosis of node-negative gastric cancer (GC) patients after curative gastrectomy in Eastern countries (China and Japan).
METHODS: The clinicopathological data of 2455 GC patients (including 1137 node-negative cases) were included to demonstrate whether a minimum NELN is inevitable for guaranteeing the accurate prognosis of node-negative GC patients after curative gastrectomy.
RESULTS: Survival analyses revealed that the NELN significantly positively correlated with overall survival (p < 0.001) and was an independent prognostic predictor (hazard ratio 0.447; p = 0.025) of 1137 node-negative GC patients. Stratum analysis within the Kaplan-Meier method showed that sex, tumor size, and extent of lymphadenectomy did not affect the NELN in predicting the prognosis of all node-negative GC patients. Stage migration was mainly detected in the subgroup of node-negative GC Chinese patients who presented considerably lower mean NELN and more advanced staging than patients from Japan. The NELN was identified as the most intensively independent predictor of prognosis of 600 node-negative GC patients from China, with the smallest Akaike information criterion (176.964) and Bayesian information criterion values (194.552). These findings indicate that increasing the NELN is a prerequisite to guaranteeing precise TNM classification.
CONCLUSIONS: The NELN should be considered a mandatory requirement for improving the accuracy of prognostic evaluation of GC patients, especially for advanced-stage patients.

Entities:  

Mesh:

Year:  2016        PMID: 27770340     DOI: 10.1245/s10434-016-5513-8

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  21 in total

Review 1.  Prognostic impact of nodal status and therapeutic implications.

Authors:  Katja Ott; Susanne Blank; Laura Ruspi; Margit Bauer; Leila Sisic; Thomas Schmidt
Journal:  Transl Gastroenterol Hepatol       Date:  2017-03-15

2.  Should All Stage N3b Patients with Advanced Gastric Cancer Be Considered Equivalent? A 30-Year Single Center Study.

Authors:  Zhe Zhang; Jin-Yu Huang; Peng-Liang Wang; Wen-Bin Hou; Song-Cheng Yin; Hui-Mian Xu
Journal:  J Gastrointest Surg       Date:  2018-09-20       Impact factor: 3.452

3.  Gastric cancer lymph node resection-the more the merrier?

Authors:  Henrik Nienhüser; Thomas Schmidt
Journal:  Transl Gastroenterol Hepatol       Date:  2018-01-05

4.  Survival impact of the number of lymph node retrieved on patients with node-negative gastric cancer: more is better?

Authors:  Jun-Te Hsu; Puo-Hsien Le; Chia-Jung Kuo; Ta-Sen Yeh; Yi-Yin Jan
Journal:  Transl Gastroenterol Hepatol       Date:  2017-12-07

5.  Insufficient examined lymph node count underestimates staging in pN3a patients after curative gastrectomy: a multicenter study with external validation.

Authors:  Yinping Dong; Yiran Qiu; Jingyu Deng; Wei Wang; Zhe Sun; Zhenning Wang; Zhiwei Zhou; Huimian Xu; Han Liang
Journal:  J Cancer Res Clin Oncol       Date:  2019-12-07       Impact factor: 4.553

6.  Impact of retrieved lymph node count on short-term complications in patients with gastric cancer.

Authors:  Feng Sun; Song Liu; Peng Song; Chen Zhang; Zhijian Liu; Wenxian Guan; Meng Wang
Journal:  World J Surg Oncol       Date:  2020-08-24       Impact factor: 2.754

7.  Comparison of gastric cancer survival after R0 resection in the US and China.

Authors:  Ping Li; Chang-Ming Huang; Chao-Hui Zheng; Ashley Russo; Priyanka Kasbekar; Murray F Brennan; Daniel G Coit; Vivian E Strong
Journal:  J Surg Oncol       Date:  2018-10-17       Impact factor: 3.454

8.  Greater Lymph Node Retrieval Improves Survival in Node-Negative Resected Gastric Cancer in the United States.

Authors:  Katelin A Mirkin; Christopher S Hollenbeak; Joyce Wong
Journal:  J Gastric Cancer       Date:  2017-11-21       Impact factor: 3.720

9.  Validation of clinical significance of examined lymph node count for accurate prognostic evaluation of gastric cancer for the eighth edition of the American Joint Committee on Cancer (AJCC) TNM staging system.

Authors:  Jingyu Deng; Jinyuan Liu; Wei Wang; Zhe Sun; Zhenning Wang; Zhiwei Zhou; Huimian Xu; Han Liang
Journal:  Chin J Cancer Res       Date:  2018-10       Impact factor: 5.087

10.  Observation of tumor-associated macrophages expression in gastric cancer and its clinical pathological relationship.

Authors:  Qing Zhu; Xia Wu; Mingyang Tang; Ligao Wu
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.